(a) Trastuzumab scFv (lane 1: soluble lysate (reducing),lane 2: purified (reducing),lane 3: purified (non-reducing). antibody fragments have emerged as a particularly exciting therapeutic modality due to their high specificity for a given target, which is usually thought to reduce the Ceftiofur hydrochloride adverse effects associated with treatment.1Because of this, the […]
Daily Archives: May 1, 2025
1 post